Wolf D - Search Results

1

Overcoming immunotherapy resistance in non-small cell lung cancer (NSCLC) - novel approaches and future outlook.

Horvath L, Thienpont B, Zhao L, Wolf D, Pircher A. Horvath L, et al. Among authors: wolf d. Mol Cancer. 2020 Sep 11;19(1):141. doi: 10.1186/s12943-020-01260-z. Mol Cancer. 2020. PMID: 32917214 Free PMC article. Review.

2

Durable complete remission in a patient with recurrent DLBCL receiving rituximab monotherapy after high-dose chemotherapy and autologous stem cell transplantation.

Pircher A, Gassner EM, Steurer M, Wolf D. Pircher A, et al. Among authors: wolf d. BMJ Case Rep. 2012 Jul 3;2012:bcr0220125856. doi: 10.1136/bcr.02.2012.5856. BMJ Case Rep. 2012. PMID: 22761205 Free PMC article.

3

Neoadjuvant chemo-immunotherapy modifies CD4(+)CD25(+) regulatory T cells (Treg) in non-small cell lung cancer (NSCLC) patients.

Pircher A, Gamerith G, Amann A, Reinold S, Popper H, Gächter A, Pall G, Wöll E, Jamnig H, Gastl G, Wolf AM, Hilbe W, Wolf D. Pircher A, et al. Among authors: wolf d, wolf am. Lung Cancer. 2014 Jul;85(1):81-7. doi: 10.1016/j.lungcan.2014.04.001. Epub 2014 Apr 13. Lung Cancer. 2014. PMID: 24780112

4

Treg(s) in Cancer: Friends or Foe?

Wolf D, Sopper S, Pircher A, Gastl G, Wolf AM. Wolf D, et al. Among authors: wolf am. J Cell Physiol. 2015 Nov;230(11):2598-605. doi: 10.1002/jcp.25016. J Cell Physiol. 2015. PMID: 25913194 Review.

5

Synergies of Targeting Tumor Angiogenesis and Immune Checkpoints in Non-Small Cell Lung Cancer and Renal Cell Cancer: From Basic Concepts to Clinical Reality.

Pircher A, Wolf D, Heidenreich A, Hilbe W, Pichler R, Heidegger I. Pircher A, et al. Among authors: wolf d. Int J Mol Sci. 2017 Oct 31;18(11):2291. doi: 10.3390/ijms18112291. Int J Mol Sci. 2017. PMID: 29088109 Free PMC article. Review.

6

Low-dose vemurafenib in hairy cell leukemia patients with active infection.

Bohn JP, Pircher A, Wanner D, Vill D, Foeger B, Wolf D, Steurer M. Bohn JP, et al. Among authors: wolf d. Am J Hematol. 2019 Jun;94(6):E180-E182. doi: 10.1002/ajh.25474. Epub 2019 Apr 4. Am J Hematol. 2019. PMID: 30916799 Free PMC article. No abstract available.

7

Immunotherapy-Based Targeting and Elimination of Leukemic Stem Cells in AML and CML.

Valent P, Sadovnik I, Eisenwort G, Bauer K, Herrmann H, Gleixner KV, Schulenburg A, Rabitsch W, Sperr WR, Wolf D. Valent P, et al. Among authors: wolf d. Int J Mol Sci. 2019 Aug 29;20(17):4233. doi: 10.3390/ijms20174233. Int J Mol Sci. 2019. PMID: 31470642 Free PMC article. Review.

8

Angiogenesis inhibition in non-small cell lung cancer: a critical appraisal, basic concepts and updates from American Society for Clinical Oncology 2019.

Cantelmo AR, Dejos C, Kocher F, Hilbe W, Wolf D, Pircher A. Cantelmo AR, et al. Among authors: wolf d. Curr Opin Oncol. 2020 Jan;32(1):44-53. doi: 10.1097/CCO.0000000000000591. Curr Opin Oncol. 2020. PMID: 31609741 Review.

9

High RIG-I expression in ovarian cancer associates with an immune-escape signature and poor clinical outcome.

Wolf D, Fiegl H, Zeimet AG, Wieser V, Marth C, Sprung S, Sopper S, Hartmann G, Reimer D, Boesch M. Wolf D, et al. Int J Cancer. 2020 Apr 1;146(7):2007-2018. doi: 10.1002/ijc.32818. Epub 2019 Dec 19. Int J Cancer. 2020. PMID: 31800094 Free PMC article.

10

Cloak and dagger - secondary hemophygocytic lymphohistiocytosis caused by intravenous autoinfection.

Pircher A, Koeck S, Schatzlmayr J, Finkenstedt A, Nairz M, Wanner D, Griesmacher A, Tilg H, Wolf D, Zoller H. Pircher A, et al. Among authors: wolf d. Am J Hematol. 2020 Mar;95(3):330-332. doi: 10.1002/ajh.25704. Epub 2019 Dec 24. Am J Hematol. 2020. PMID: 31849105 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,910 results

Search Page

Filters